Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Genentech funds basic research related to human birth defects

Feb. 10, 1997

Vyrex gene discovery platform receives patent coverage

Feb. 10, 1997

Zynaxis sells drug delivery technology

Feb. 7, 1997

Abgenix reports significant advance in human antibody technology

Feb. 6, 1997

LifeTECH and Pall announce collaboration

Feb. 6, 1997

ICOS/Glaxo Wellcome collaboration modified

Feb. 4, 1997

Cytogen/Elan oral drug delivery collaboration advances

Feb. 4, 1997

Zeneca/Pharmacopeia collaboration signed

Jan. 31, 1997

Terrapin and Sosei commence drug discovery collaboration

Jan. 30, 1997

Genelabs granted patent coverage for gene-regulating drugs

Jan. 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.